🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is looking at outcomes in people with advanced cancers who have ...
Status
Terminated
Location
Peter MacCallum Cancer Centre
Start Date
2021-09-23
Trial ID
NCT04801966
This is a Phase II single-arm window trial to assess the clinical and biolo...
Status
Terminated
Location
University of Arizona
Start Date
2021-07-07
Trial ID
NCT04169074
Treatments Being Tested
This study is being done to see how safe and effective abemaciclib is when ...
Status
Active Not Recruiting
Location
St. Joseph's Hospital and Medical Center
Start Date
2018-11-26
Trial ID
NCT03706365
Treatments Being Tested
A Phase Ib/III Open-label, Randomised Study of Capivasertib plus CDK4/6 Inh...
Status
Active Not Recruiting
Location
Research Site
Start Date
2021-05-10
Trial ID
NCT04862663
Treatments Being Tested
This research is studying two experimental drugs, abemaciclib and atezolizu...
Status
Withdrawn
Location
Dana-Farber Cancer Institute
Start Date
2020-10
Trial ID
NCT04272645
Treatments Being Tested
The ATLANT study is prospective, multicentre, non-interventional, observati...
Status
Completed
Location
Russian Society of Clinical Oncology
Start Date
2022-04-01
Trial ID
NCT05789771
Treatments Being Tested
The purpose of this study is to assess how the body handles Abemaciclib whe...
Status
Completed
Location
Accelerated Comm. Oncology Research Network (ACORN)
Start Date
2014-04
Trial ID
NCT02117648
Treatments Being Tested
Background: Kaposi Sarcoma (KS) is common in people with human immunodefic...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2021-09-29
Trial ID
NCT04941274
Treatments Being Tested
The study will evaluate how safe and effective abemaciclib is when given to...
Status
Completed
Location
University of Utah - Huntsman Cancer Institute
Start Date
2021-01-20
Trial ID
NCT04408924
Treatments Being Tested
This is a multicenter, Phase 1b/2 trial in participants with estrogen recep...
Status
Active Not Recruiting
Location
Dothan Hematology and Oncology
Start Date
2023-01-24
Trial ID
NCT05563220
Treatments Being Tested